GoBroad Clinical Research Center helps clients to develop medical strategies throughout the clinical development of products. Our medical experts have years of clinical practice experience in top-tier hospitals, and solid experience in clinical development of various innovative drugs in the industry. Leded by medical experts, our multidisciplinary team conducts literature research, collects competitive information, analyzes unmet needs in the relevant therapeutic areas, with regulatory requirements taken into account, to develop differentiated medical strategies in the clinical development phase for clients. Our services include clinical trial design, medical support for communication with regulatory authorities, and other medical support during the clinical development and trials.

With rich experience in early clinical development strategies and clinical trial design, our expertise spans various areas, including first-in-human trials for Class 1 chemical drugs and biologics, clinical pharmacology studies (e.g. drug-drug interactions (DDI), isotope-labeled mass balance studies, cardiotoxicity assessments, etc.), and studies of new therapies modalities, such as cell therapy, gene therapy, oncolytic viruses, antibody-drug conjugates (ADC), as well as bispecific and multispecific antibodies. Therapeutic areas we experienced cover oncology, hematology, rheumatology, immunology, gastroenterology, endocrinology, and metabolism.